Australia Diagnostic Imaging Equipment Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

Market Overview

The Australia diagnostic imaging equipment market is entering a build-out phase. Medicare licensing once limited where high-value scanners could earn rebates, but practice-based MRI licensing and state hospital programs are now widening demand for new MRI, CT and nuclear imaging systems.

Three forces are shaping the market: Medicare reform of MRI eligibility, which Philips says lifted subsidised MRI units from 227 to 620; state investment led by Queensland, with more than AUD 270 million for new MRI and CT capacity; and a technology shift towards AI reconstruction, helium-light magnets and PET systems suited to theranostics.

In February 2026 the new Footscray Hospital opened with three CT scanners and three MRI machines, in May 2026 Jardine Matheson agreed to buy I-MED Radiology at an enterprise value of AUD 3.4 billion, and the government confirmed yearly PSMA PET scans from 1 November 2026.

Key Market Trends and Insights

• Medicare MRI reform: Practice-based licensing replaced equipment-based licences on 1 July 2025, and Philips reported in August 2026 that subsidised MRI units grew from 227 to 620, opening a large replacement pipeline.
• State hospital programs: Queensland's statewide program funds six MRI machines and nine CT scanners across 11 sites, while Footscray Hospital lifted MRI capacity from one machine to three in February 2026.
• Provider scale: Integral Diagnostics ran 42 Australian MRI machines at 30 June 2026, up from 23 a year earlier, after integrating Capitol Health and lifting revenue to AUD 788.7 million.
• Theranostics demand: PSMA PET/CT access moves from two scans per lifetime to yearly scans for eligible men from 1 November 2026, supporting orders for PET and hybrid systems.

Australia Diagnostic Imaging Equipment Market Size and Forecast

The market is moving from ageing, licence-constrained fleets towards larger, faster and more software-driven installations that match Medicare eligibility and hospital build programs. Ultrasound leads because it serves the widest range of clinical uses, while nuclear imaging and AI-enabled systems advance fastest as theranostics and reconstruction software raise the value of each scanner. Diagnostic imaging centres expand quickest among buyers as corporate groups add MRI capacity, and Queensland grows fastest among the states, with New South Wales remaining the larger base. Medicare reform, hospital capital programs and helium-light magnet designs underpin a durable multi-year outlook rather than a cyclical uplift.

Key Takeaways: Australia Diagnostic Imaging Equipment Market

Medicare Reform Anchors Replacement Demand

Revenue is on course to expand by about 68% across the decade, from AUD 1,150.00 million in 2025 to AUD 1,927.44 million in 2035 at a 5.3% CAGR. Practice-based MRI licensing and a possible second stage from July 2027 keep replacement and expansion orders flowing to scanner suppliers.

Nuclear Imaging and AI-Enabled Systems Lead Growth

Ultrasound holds the largest revenue share, but nuclear imaging grows at an estimated 7.1% CAGR and AI-enabled systems at an estimated 8.4% CAGR through 2035. Yearly PSMA PET access and the Peter MacCallum total body PET/CT show how theranostics and software reshape purchasing.

I-MED Sale Reshapes the Imaging Buyer Landscape

Jardine Matheson agreed in May 2026 to acquire I-MED Radiology at an enterprise value of AUD 3.4 billion, with completion expected in late 2026. The buyer will shape purchasing across one of the country's largest scanner fleets.

• 215 clinics across Australia and New Zealand
• More than 500 radiologists in Australia
• Seller is funds advised by Permira

Australia Diagnostic Imaging Equipment Market Report Summary

Key Insight

The trajectory reflects structural reform rather than a cycle. Medicare licensing, hospital builds and theranostics lift orders, while AI software and hybrid systems raise the value of each scanner sold.

Key Trends in the Australia Diagnostic Imaging Equipment Market

The Australia diagnostic imaging equipment market is being reshaped by regional hospital builds, helium-light MRI, Medicare fee changes and state scanner investment.

September 2026 - NSW Delivers First Public MRI and CT Equipment to Eurobodalla Regional Hospital

• NSW Health said on 11 September 2026 that the region's first public MRI machine and a new CT scanner, with ultrasound and fluoroscopy units, had been delivered.
• Imaging services are expected to start in 2027, after the AUD 330 million hospital is completed.
• The equipment supports cardiac imaging and stroke diagnosis, reducing travel for patients on the south coast.

August 2026 - Philips Highlights Helium-Light MRI as the Subsidised Fleet Expands

• Philips Australia and New Zealand wrote in August 2026 that Medicare reform nearly tripled subsidised MRI units, from 227 to 620.
• A conventional MRI needs about 1,500 litres of liquid helium, while Philips BlueSeal sealed magnets use about 7 litres.
• Philips counts more than 2,000 BlueSeal systems installed worldwide, steering helium-wary buyers towards sealed designs.

July 2026 - Medicare Imaging Changes Take Effect on 1 July 2026

• The Department of Health removed breast imaging co-claiming restrictions from 1 July 2026, allowing several services on the same day.
• Fees rose for gallium-67 and thallium-201 nuclear medicine services, reflecting higher sustained input costs.
• Imaging request forms now stay valid for 14 days instead of 7, easing patient scheduling across scanner fleets.

May 2026 - Queensland Adds a CT Scanner at Charleville Within a Statewide Imaging Program

• Health Minister Tim Nicholls announced on 26 May 2026 more than AUD 270 million for imaging technology across 11 Queensland locations.
• Charleville Hospital will receive a CT scanner within an imaging hub with ultrasound and X-ray.
• The scanner is expected to start at about 40 scans a month, rising above 1,000 a year after its first year.

Key Insight

Growth is structurally locked in rather than cyclical. Reimbursement reform sets the direction, public capital programs supply the volume, and sealed magnets and nuclear imaging mark the technology shift.

Recent Market Developments in the Australia Diagnostic Imaging Equipment Market

Recent developments, presented from the most recent, show the Australia diagnostic imaging equipment market moving from provider results and ownership change into new hospitals and research installations.

August 2026 - Integral Diagnostics Reports FY26 Results With Capitol Synergies Ahead of Plan

• Integral Diagnostics reported on 25 August 2026 revenue of AUD 788.7 million, up 25.6%, and operating EBITDA of AUD 164.8 million.
• Its Australian MRI fleet reached 42 machines at 30 June 2026, from 23 a year earlier, across 142 sites.
• It guided fiscal 2027 capital expenditure of AUD 50 million to AUD 60 million, signalling continued scanner purchasing.

May 2026 - Jardine Matheson Agrees to Acquire I-MED Radiology From Permira

• Jardine Matheson announced on 25 May 2026 an agreement to acquire I-MED Radiology Network from funds advised by Permira.
• The enterprise value is AUD 3.4 billion for a network of 215 clinics across Australia and New Zealand.
• Completion is expected in late 2026, subject to regulatory approvals, keeping a major scanner buyer in play.

February 2026 - New Footscray Hospital Opens With Expanded CT and MRI Capacity

• The Victorian Government opened Footscray Hospital on 18 February 2026.
• Three premium CT scanners, one in the emergency department, speed up radiology, and MRI capacity rises from one machine to three.
• The imaging department also adds the first PET-CT at a Western Health facility.

November 2025 - Peter MacCallum Cancer Centre Launches ACRF Imaging Centres Around Total Body PET/CT

• Peter MacCallum launched two Australian Cancer Research Foundation centres on 17 November 2025, supported by about AUD 15 million in grants.
• The centres use a GE HealthCare total body PET/CT, which Peter Mac says is the first site globally to install the technology.
• The scanner joins the National Imaging Facility network, opening access for researchers nationally.

Key Insight

The sequence shows a shift from planning to delivery. Provider results, ownership change and new hospitals confirm sustained scanner purchasing, while research installations preview the next generation of PET technology.

Australia Diagnostic Imaging Equipment Industry Segmentation

The Expert Market Research’s report on the Australia Diagnostic Imaging Equipment Market offers a detailed analysis of the market based on the following segments.

Market Breakup by Modality

• Ultrasound
• X-Ray and Fluoroscopy
• Computed Tomography
• Magnetic Resonance Imaging
• Nuclear Imaging
• Others

Ultrasound leads because it recorded 12.9 million Medicare-subsidised services in the year to June 2025, the most of any modality. Nuclear Imaging grows fastest at an estimated 7.1% CAGR through 2035, backed by yearly PSMA PET access from 1 November 2026 and a Siemens Biograph Trinion PET-CT due at Imaging Associates in Footscray in October 2026. Magnetic Resonance Imaging gains from subsidised units rising from 227 to 620, and Computed Tomography from three scanners at Footscray Hospital, opened in February 2026. X-Ray and Fluoroscopy is a replacement-led segment. Others covers mammography and interventional systems, where breast imaging claiming rules eased in July 2026.

Market Breakup by Technology

• Digital Imaging Systems
• Hybrid and Multimodality Systems
• AI-Enabled Systems
• Portable and Point-of-Care Systems
• Analogue and Legacy Systems
• Others

Digital Imaging Systems lead because nearly every new detector, scanner and ultrasound console sold is digital, and the University of Sydney opened a Siemens Cima.X 3T MRI research facility in September 2025. AI-Enabled Systems grow fastest at an estimated 8.4% CAGR through 2035, as Philips promotes reconstruction that cuts scan times by up to threefold. Hybrid and Multimodality Systems cover PET/CT, SPECT/CT and PET/MR, including the GE HealthCare total body PET/CT at Peter Mac. Portable and Point-of-Care Systems serve emergency and regional sites, while Analogue and Legacy Systems shrink as ageing units are retired.

Market Breakup by End User

• Hospitals
• Diagnostic Imaging Centres
• Specialist and Referral Clinics
• Research and Academic Institutes
• Others

Hospitals lead because public and private campuses buy the broadest scanner fleets, and Footscray Hospital opened on 18 February 2026 with three CT scanners and three MRI machines. Diagnostic Imaging Centres grow fastest at an estimated 6.2% CAGR through 2035, as Integral Diagnostics lifted its Australian MRI fleet from 23 to 42 machines by June 2026 and Jardine Matheson agreed to buy I-MED in May 2026. Specialist and Referral Clinics buy compact ultrasound and X-ray systems for cardiology, women's health and orthopaedics. Research and Academic Institutes include the University of Newcastle, which sought tenders in August 2026 for preclinical MRI, PET and CT. Others covers mobile and aged care imaging.

Market Breakup by Region

• New South Wales
• Victoria
• Queensland
• Western Australia
• South Australia
• Others

New South Wales dominates through its large teaching hospital and private provider base, and it grows at an estimated 5.1% CAGR through 2035; NSW Health delivered the Eurobodalla Regional Hospital MRI and CT equipment in September 2026. Queensland is the fastest-growing state at an estimated 5.9%, helped by a program of more than AUD 270 million for six MRI machines and nine CT scanners. Victoria grows at 5.2%, with Footscray Hospital opened in February 2026, and Western Australia at 5.4%, as regional sites favour compact CT and ultrasound. South Australia grows at 5.0%, supported by research-linked imaging. Others covers Tasmania, the ACT and the Northern Territory at 4.9%.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Competitive Landscape in the Australia Diagnostic Imaging Equipment Market

Competition combines global scanner makers, large provider groups that buy in volume and specialist suppliers. Entry barriers include therapeutic goods registration, local service engineering, Medicare equipment eligibility rules and the hospital tender relationships that anchor multi-year supply.

Siemens Healthineers

Siemens Healthineers, headquartered in Erlangen, Germany, supplies MRI, CT, PET-CT, X-ray and ultrasound systems, including the MAGNETOM and NAEOTOM ranges. In September 2025 it partnered with the University of Sydney on a Cima.X 3T MRI research facility, and in August 2026 Imaging Associates said its new Footscray clinic, opening in October 2026, would house a Biograph Trinion PET-CT.

GE HealthCare

GE HealthCare, headquartered in Chicago, Illinois, makes CT, MRI, PET/CT, ultrasound, X-ray and mammography systems and imaging software. In November 2025 Peter MacCallum Cancer Centre launched two Australian Cancer Research Foundation centres built around a GE HealthCare total body PET/CT, which Peter Mac says is the first site globally to install the technology.

Philips

Royal Philips, headquartered in Amsterdam, the Netherlands, supplies MRI, CT, ultrasound, X-ray and image-guided therapy systems, and reported 2025 sales of EUR 18 billion. Its BlueSeal sealed-magnet MRI uses about 7 litres of helium, and in August 2026 Philips Australia and New Zealand said the Medicare-subsidised MRI fleet had grown from 227 to 620 units. It counts more than 2,000 BlueSeal systems installed worldwide.

Integral Diagnostics

Integral Diagnostics, listed on the ASX as IDX, operates 142 radiology sites across Australia and New Zealand and buys CT, MRI, ultrasound and X-ray systems for them. On 25 August 2026 it reported fiscal 2026 revenue of AUD 788.7 million, up 25.6%, after integrating Capitol Health, and 42 Australian MRI machines against 23 a year earlier. It guided fiscal 2027 capital expenditure of AUD 50 million to AUD 60 million.

Other players operating in the Australia diagnostic imaging equipment market include Canon Medical, Fujifilm, United Imaging, I-MED Radiology, and Lumus Imaging, alongside regional distributors, service engineering firms and AI software developers supporting purchasing across Australia.

Key Insight

Competition rests on installed base, service reach, software capability and tender relationships rather than price alone. Global manufacturers and large provider groups shape purchasing, while consolidation concentrates buying power.